Coussa Ayla, Barber Thomas M, Khrait Zakwan, Cheaib Samer, Hasan Hayder A
Division of Biomedical Sciences (T.M.B.), Warwick Medical School, University of Warwick, Clinical Sciences Research Laboratories, University Hospitals Coventry and Warwickshire, Clifford Bridge Road, Coventry, CV2 2DX, United Kingdom.
Fakih IVF Fertility Center, Jumeirah, Dubai, United Arab Emirates.
J Hum Reprod Sci. 2022 Apr-Jun;15(2):163-170. doi: 10.4103/jhrs.jhrs_168_21. Epub 2022 Jun 1.
Thyroid dysfunction impairs female fertility and pregnancy outcome. Optimal preconception and gestational TSH level is still debatable in IVF-conceived pregnancies.
To explore the relationships of IVF success and pregnancy outcomes with maternal serum levels of TSH (at both preconception and 12-week IVF-conceived pregnancy). Also, to confirm or refute the recommended TSH level ≤2.5μIU/mL.
Retrospective cohort.
158 IVF-conceived pregnant women and 117 age-matched controls non-pregnant (≤39years, BMI 18.5-38kg/m2) were recruited. Preconception and 12-week IVF-conceived pregnancy serum samples were analysed for reproductive hormones, fasting glucose, insulin and TSH levels. Data of pregnant women at 28 weeks for GDM screening (75-gram OGTT) and up until delivery were included.
Binary logistic regression used to predict association between preconception TSH levels and IVF success, and pregnancy outcomes. Association of delta change of hormones was determined with linear regression. Significance level ≤0.05 with 95% confidence interval (CI).
Overall, median (IQR) age was 32(6)years, BMI 25.4(6.9)kg/m2, HbA1c 5.2(0.52)% and TSH 1.82(1.4)μIU/mL. There was no significant association between preconception TSH level and IVF success rate. During the first trimester of IVF-conceived pregnancy, delta change in TSH level was associated with that of progesterone (P=0.03). 12-week gestation TSH level did not predict adverse pregnancy outcomes (i.e. onset of GDM, delivery type and premature delivery); but a higher TSH level predicted earlier delivery in weeks. There was a higher risk of delivery by caesarean section when TSH>2.5μIU/mL.
Variation of maternal TSH within normal range (0.4-4.0μIU/mL) at preconception and 12-week gestation has no predictive effect on IVF success and pregnancy outcomes in IVF-pregnancy. Our data provide no support for a recommended preconception TSH level ≤2.5μIU/mL in IVF-conceived pregnancy, but rather promote a preconception TSH level within normal range.
甲状腺功能障碍会损害女性生育能力和妊娠结局。在体外受精(IVF)受孕的妊娠中,孕前和孕期促甲状腺激素(TSH)的最佳水平仍存在争议。
探讨IVF成功率和妊娠结局与母体血清TSH水平(孕前和IVF受孕12周时)之间的关系。此外,证实或反驳推荐的TSH水平≤2.5μIU/mL。
回顾性队列研究。
招募了158例IVF受孕的孕妇和117例年龄匹配的未孕对照者(年龄≤39岁,体重指数18.5 - 38kg/m²)。分析孕前和IVF受孕12周时的血清样本中的生殖激素、空腹血糖、胰岛素和TSH水平。纳入孕妇28周时进行妊娠期糖尿病(GDM)筛查(75克口服葡萄糖耐量试验)的数据以及直至分娩的数据。
采用二元逻辑回归预测孕前TSH水平与IVF成功率及妊娠结局之间的关联。用线性回归确定激素变化量之间的关联。显著性水平≤0.05,95%置信区间(CI)。
总体而言,中位(四分位间距)年龄为32(6)岁,体重指数25.4(6.9)kg/m²,糖化血红蛋白5.2(0.52)%,TSH 1.82(1.4)μIU/mL。孕前TSH水平与IVF成功率之间无显著关联。在IVF受孕妊娠的孕早期,TSH水平的变化量与孕酮的变化量相关(P = 0.03)。妊娠12周时的TSH水平不能预测不良妊娠结局(即GDM的发生、分娩方式和早产);但TSH水平较高可预测分娩周数提前。TSH>2.5μIU/mL时剖宫产分娩的风险较高。
孕前和妊娠12周时母体TSH在正常范围内(0.4 - 4.0μIU/mL)的变化对IVF受孕妊娠的IVF成功率和妊娠结局无预测作用。我们的数据不支持在IVF受孕妊娠中推荐孕前TSH水平≤2.5μIU/mL,而是提倡孕前TSH水平在正常范围内。